The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes
Open accessAbstract
Adverse drug reactions (ADRs) are a major cause of hospital admissions, but recent data on the incidence and clinical characteristics of ADRs which occur following hospital admission, are lacking. Patients admitted to twelve wards over a six-month period in 2005 were assessed for ADRs throughout their admission. Suspected ADRs were recorded and analysed for causality, severity and avoidability and whether they increased the length of stay. Multivariable analysis was undertaken to identify the risk factors for ADRs. The 5% significance level was used when assessing factors for inclusion in multivariable models. Out of the 3695 patient episodes assessed for ADRs, 545 (14.7%, 95% CI 13.6-15.9%) experienced one or more ADRs. Half of ADRs were definitely or possibly avoidable. The patients experiencing ADRs were more likely to be older, female, taking a larger number of medicines, and had a longer length of stay than those without ADRs. However, the only significant predictor of ADRs, from the multivariable analysis of a representative sample of patients, was the number of medicines taken by the patient with each additional medication multiplying the hazard of an ADR episode by 1.14 (95% CI 1.09, 1.20). ADRs directly increased length of stay in 147 (26.8%) patients. The drugs most frequently associated with ADRs were diuretics, opioid analgesics, and anticoagulants. In conclusion, approximately one in seven hospital in-patients experience an ADR, which is a significant cause of morbidity, increasing the length of stay of patients by an average of 0.25 days/patient admission episode. The overall burden of ADRs on hospitals is high, and effective intervention strategies are urgently needed to reduce this burden.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A method for estimating the probability of adverse drug reactions
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., & Greenblatt, D. J. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.154 · Cited by 11,914 · cited 2×
“2%) suspected ADRs were subsequently excluded by the investigating team, on the basis that an ADR was unlikely to be drug related according to the Naranjo algorithm [15].”
MethodIncidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
Pirmohamed, M., James, S., Meakin, S., Green, C., Scott, A. K., Walley, T. J., Farrar, K., Park, B. K., & Breckenridge, A. M. (2004) · BMJ · doi:10.1136/bmj.329.7456.15 · Cited by 3,230
Self-citationAdverse drug reactions: definitions, diagnosis, and management
Edwards, I. R., & Aronson, J. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02799-9 · Cited by 2,979
(1958) · Journal of the American Pharmaceutical Association (Scientific ed.) · doi:10.1002/jps.3030470133 · Cited by 2,489
Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention
Bates, D. W. (1995) · JAMA · doi:10.1001/jama.1995.03530010043033 · Cited by 2,127
Bates, D. W. (1997) · JAMA · doi:10.1001/jama.277.4.307 · Cited by 1,674
Pharmacist Participation on Physician Rounds and Adverse Drug Events in the Intensive Care Unit
Leape, L. L. (1999) · JAMA · doi:10.1001/jama.282.3.267 · Cited by 1,599
Applied Mixed Models in Medicine
Brown, H., & Presco, R. (2000) · Technometrics · doi:10.1080/00401706.2000.10485742 · Cited by 1,262
Classen, D. C. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540280039031 · Cited by 1,134
Cited by
Hah, J. M., Bateman, B. T., Ratliff, J., Curtin, C., & Sun, E. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002458 · Cited by 728
Adverse drug reactions in special populations – the elderly
Davies, E. A., & O'Mahony, M. S. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12596 · Cited by 604
Self-citationClinical and economic burden of adverse drug reactions
Sultana, J., Cutroneo, P., & Trifirò, G. (2013) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.120957 · Cited by 528
Epidemiology of Adverse Drug Reactions in Europe: A Review of Recent Observational Studies
Bouvy, J. C., De Bruin, M. L., & Koopmanschap, M. A. (2015) · Drug Safety · doi:10.1007/s40264-015-0281-0 · Cited by 466
Economic analysis of the prevalence and clinical and economic burden of medication error in England
Elliott, R. A., Camacho, E., Jankovic, D., Sculpher, M. J., & Faria, R. (2021) · BMJ Quality & Safety · doi:10.1136/bmjqs-2019-010206 · Cited by 425
Coleman, J. J., & Pontefract, S. K. (2016) · Clinical Medicine · doi:10.7861/clinmedicine.16-5-481 · Cited by 399
Pharmacogenomics: current status and future perspectives
Pirmohamed, M. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-022-00572-8 · Cited by 351
Self-citationAvery, A., Anderson, C., Bond, C., Fortnum, H., Gifford, A., Hannaford, P., Hazell, L., Krska, J., Lee, A., McLernon, D., et al. (2011) · Health Technology Assessment · doi:10.3310/hta15200 · Cited by 331
A Review of the Important Role of CYP2D6 in Pharmacogenomics
Taylor, C., Crosby, I., Yip, V., Maguire, P., Pirmohamed, M., & Turner, R. M. (2020) · Genes · doi:10.3390/genes11111295 · Cited by 316
Self-citationHakkarainen, K. M., Hedna, K., Petzold, M., & Hägg, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033236 · Cited by 293
OECD (2011) · Health at a glance · doi:10.1787/health_glance-2011-en · Cited by 289
Epidemiology and characteristics of adverse drug reactions caused by drug–drug interactions
Magro, L., Moretti, U., & Leone, R. (2012) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2012.631910 · Cited by 287
Jarzyna, D., Jungquist, C. R., Pasero, C., Willens, J. S., Nisbet, A., Oakes, L., Dempsey, S. J., Santangelo, D., & Polomano, R. C. (2011) · Pain Management Nursing · doi:10.1016/j.pmn.2011.06.008 · Cited by 253
Lauschke, V. M., Hendriks, D. F. G., Bell, C. C., Andersson, T. B., & Ingelman-Sundberg, M. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00150 · Cited by 241
A systematic review of factors that contribute to nocebo effects
Webster, R. K., Weinman, J., & Rubin, G. J. (2016) · Health Psychology · doi:10.1037/hea0000416 · Cited by 172
Agbabiaka, T. B., Wider, B., Watson, L. K., & Goodman, C. (2017) · Drugs & Aging · doi:10.1007/s40266-017-0501-7 · Cited by 141
Bellis, J. R., Kirkham, J. J., Nunn, A. J., & Pirmohamed, M. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12222 · Cited by 120
Self-citationShah, S. N., Amato, M. G., Garlo, K. G., Seger, D. L., & Bates, D. W. (2021) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa222 · Cited by 43
Metadata
- Authors
- Davies, E. C., Green, C. F., Taylor, S., Williamson, P. R., Mottram, D. R., & Pirmohamed, M.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-02-11
- Volume
- 4
- Issue
- 2
- Pages
- e4439
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2085074082
- Cited by
- 692
- References
- 43
- FWCI
- 51.66
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.